Compare EVR & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | EVR | BIRK |
|---|---|---|
| Founded | 1995 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | 8000 |
| Industry | Investment Managers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 6.1B |
| IPO Year | 2006 | 2023 |
| Metric | EVR | BIRK |
|---|---|---|
| Price | $271.63 | $33.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $345.67 | $62.69 |
| AVG Volume (30 Days) | 638.1K | ★ 2.1M |
| Earning Date | 04-29-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.22% | N/A |
| EPS Growth | ★ 54.74 | N/A |
| EPS | ★ 14.05 | N/A |
| Revenue | ★ $3,880,084,000.00 | N/A |
| Revenue This Year | $21.47 | $13.71 |
| Revenue Next Year | $13.38 | $14.21 |
| P/E Ratio | $19.57 | ★ $17.48 |
| Revenue Growth | ★ 29.49 | N/A |
| 52 Week Low | $148.63 | $34.28 |
| 52 Week High | $388.71 | $57.39 |
| Indicator | EVR | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 34.01 | 30.45 |
| Support Level | $265.87 | N/A |
| Resistance Level | $324.03 | $42.19 |
| Average True Range (ATR) | 10.94 | 1.52 |
| MACD | -0.28 | -0.51 |
| Stochastic Oscillator | 15.70 | 3.42 |
Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. Evercore operates globally, with a particularly strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.